Article Versions Notes

Del Bianco P, Stagni C, Giunco S, Fabozzi A, Elefanti L, Pellegrini S, Vecchiato A, Pigozzo J, Zamuner C, De Rossi A, et al. TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients. Cancers. 2020; 12(4):946. https://doi.org/10.3390/cancers12040946

Del Bianco, Paola, Camilla Stagni, Silvia Giunco, Alessio Fabozzi, Lisa Elefanti, Stefania Pellegrini, Antonella Vecchiato, Jacopo Pigozzo, Carolina Zamuner, Anita De Rossi, and et al. 2020. "TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients" Cancers 12, no. 4: 946. https://doi.org/10.3390/cancers12040946

Del Bianco, P., Stagni, C., Giunco, S., Fabozzi, A., Elefanti, L., Pellegrini, S., Vecchiato, A., Pigozzo, J., Zamuner, C., De Rossi, A., De Nicolo, A., & Menin, C. (2020). TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma Patients. Cancers, 12(4), 946. https://doi.org/10.3390/cancers12040946